Literature DB >> 22335228

Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up.

Nicole M Hijnen1, Edwin Heijman, Max O Köhler, Mika Ylihautala, Gösta J Ehnholm, Arjan W Simonetti, Holger Grüll.   

Abstract

PURPOSE: We report on the design, performance, and specifications of a dedicated set-up for the treatment of rats on a clinical magnetic resonance high intensity focused ultrasound (MR-HIFU) system.
MATERIALS AND METHODS: The small animal HIFU-compatible 4-channel MR receiver volume coil and animal support were designed as add-on to a clinical 3T Philips Sonalleve MR-HIFU system. Prolonged hyperthermia (T ≈ 42°C, 15 min) and thermal ablation (T = 65°C) was performed in vivo on subcutaneous rat tumours using 1.44 MHz acoustic frequency. The direct treatment effect was assessed with T(2)-weighted imaging and dynamic contrast enhanced (DCE-) MRI as well as histology.
RESULTS: The developed HIFU-compatible coil provided an image quality that was comparable to conventional small animal volume coils (i.e. without acoustic window), and a SNR increase by a factor of 10 as compared to the coil set-up used for clinical MR-HIFU therapy. The use of an animal support minimised far field heating and allowed precise regulation of the animal body core temperature, which varied <1°C during treatment.
CONCLUSIONS: The results demonstrated that, by using a designated set-up, both controlled hyperthermia and thermal ablation treatment of malignant tumours in rodents can be performed on a clinical MR-HIFU system. This approach provides all the advantages of clinical MR-HIFU, such as volumetric heating, temperature feedback control and a clinical software interface for use in rodent treatment. The use of a clinical system moreover facilitates a rapid translation of the developed protocols into the clinic.

Entities:  

Mesh:

Year:  2012        PMID: 22335228     DOI: 10.3109/02656736.2011.648137

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  25 in total

1.  Development of a spherically focused phased array transducer for ultrasonic image-guided hyperthermia.

Authors:  Jingfei Liu; Josquin Foiret; Douglas N Stephens; Olivier Le Baron; Katherine W Ferrara
Journal:  Phys Med Biol       Date:  2016-06-29       Impact factor: 3.609

Review 2.  Ultrasound Hyperthermia Technology for Radiosensitization.

Authors:  Lifei Zhu; Michael B Altman; Andrei Laszlo; William Straube; Imran Zoberi; Dennis E Hallahan; Hong Chen
Journal:  Ultrasound Med Biol       Date:  2019-02-14       Impact factor: 2.998

3.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

4.  Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.

Authors:  Ari Partanen; Pavel S Yarmolenko; Antti Viitala; Sunil Appanaboyina; Dieter Haemmerich; Ashish Ranjan; Genevieve Jacobs; David Woods; Julia Enholm; Bradford J Wood; Matthew R Dreher
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

5.  A simple method for determining the coagulation threshold temperature of transparent tissue-mimicking thermal therapy gel phantoms: Validated by magnetic resonance imaging thermometry.

Authors:  N Patrik Brodin; Ari Partanen; Patrik Asp; Craig A Branch; Chandan Guha; Wolfgang A Tomé
Journal:  Med Phys       Date:  2016-03       Impact factor: 4.071

6.  Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia.

Authors:  Ari Partanen; Matti Tillander; Pavel S Yarmolenko; Bradford J Wood; Matthew R Dreher; Max O Kohler
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

7.  Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized 13 C dual-agent imaging of metabolism and perfusion.

Authors:  Jessie E Lee; Chris J Diederich; Robert Bok; Renuka Sriram; Romelyn Delos Santos; Susan M Noworolski; Vasant A Salgaonkar; Matthew S Adams; Daniel B Vigneron; John Kurhanewicz
Journal:  NMR Biomed       Date:  2018-07-18       Impact factor: 4.044

Review 8.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

9.  Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.

Authors:  Nicole Hijnen; Esther Kneepkens; Mariska de Smet; Sander Langereis; Edwin Heijman; Holger Grüll
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-31       Impact factor: 11.205

10.  Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.

Authors:  Simone Limmer; Jasmin Hahn; Rebecca Schmidt; Kirsten Wachholz; Anja Zengerle; Katharina Lechner; Hansjörg Eibl; Rolf D Issels; Martin Hossann; Lars H Lindner
Journal:  Pharm Res       Date:  2014-03-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.